VNDA - Vanda Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue165,083146,017109,925
Cost of Revenue17,84824,71223,462
Gross Profit147,235121,30586,463
Operating Expenses
Research Development38,54729,15629,145
Selling General and Administrative123,84199,78784,531
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-16,903-18,571-40,185
Income from Continuing Operations
Total Other Income/Expenses Net1,472665320
Earnings Before Interest and Taxes-15,431-17,906-39,865
Interest Expense---
Income Before Tax-15,431-17,906-39,865
Income Tax Expense136104-
Minority Interest---
Net Income From Continuing Ops-15,567-18,010-39,865
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-15,567-18,010-39,865
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-15,567-18,010-39,865